Communiqués Edwards Lifesciences Corporation

Actions

EW

US28176E1082

Equipement et technologie médicale avancés

Marché Fermé - Nyse Autres places de cotation 22:00:02 21/05/2025			Varia. 5j.	Varia. 1 janv.
76,10 ^USD	-2,22%		-0,85%	+2,80%

13/05	Edwards Lifesciences Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 10:40 AM
13/05	EDWARDS LIFESCIENCES CORPORATION : Piper Sandler optimiste sur le dossier	ZM

Communiqués

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes	08:31	BU
Edwards Lifesciences : Annual Stockholder Meeting Transcript	10/05	PU
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference	06/05	BU
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis	01/05	BU
Edwards Lifesciences Reports First Quarter Results	23/04	BU
Edwards Lifesciences : Corporate Impact report (2024 corporate impact report summary)	22/04	PU
Edwards Lifesciences : 2024 ESG Metrics	21/04	PU
Eight-Year Data Confirm Long-Term Durability of Edwards Lifesciences' RESILIA Tissue	21/04	AQ
Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue	18/04	BU
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025	16/04	BU
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System	14/04	BU
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients	31/03	BU
Edwards Lifesciences : 2024 Corporate Impact report	27/03	PU
Edwards Lifesciences : 2024 Corporate Impact report content index	27/03	PU
Edwards Lifesciences : 2024 GHG Assurance Statement	27/03	PU
Edwards Lifesciences : 2024 CDP Climate Change Response	27/03	PU
Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor	07/03	AQ
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference	25/02	BU
EDWARDS LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW	22/02	PR
Edwards Lifesciences : Reports Fourth Quarter 2024 Results	13/02	PU
Edwards Lifesciences Reports Fourth Quarter Results	11/02	BU
EDWARDS LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW	08/02	PR
EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW	07/02	BU
Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025	04/02	BU
EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW	25/01	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Edwards Lifesciences Corporation : L’histoire se poursuit

Le 23 avril 2024 à 10:36